Marea Therapeutics is a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardio-endocrine diseases. The company’s lead program, MAR001, is in Phase 2 clinical development for adults with metabolic dysfunction and high risk for cardiovascular disease. The company is also advancing MAR002 for the treatment of acromegaly.
Company Details
- Employees
- 33
- Address
- San Francisco, Ca, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.mareatx.com
- HQ
- San Francisco, CA
Marea Therapeutics Questions
Marea Therapeutics's website is http://www.mareatx.com
Marea Therapeutics's LinkedIn profile is https://www.linkedin.com/company/marea-therapeutics
Marea Therapeutics has
33 employees.
View email and phone details for 33
employees at Marea Therapeutics.
Marea Therapeutics's industry is
Biotechnology Research
Marea Therapeutics's top competitors are
Bluejay Therapeutics,
Sonothera,
Tenvie Therapeutics,
Futurehouse,
Nuvig Therapeutics Inc.,
Curve Biosciences,
Bitterroot Bio,
Aikium Inc.,
Siteone Therapeutics, Inc.,
Arda Therapeutics.
Marea Therapeutics's categories are Biotechnology Research
